Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UBT251 in Obese Participants With Moderate-to-Severe Obstructive Sleep Apnea (OSA) on Positive Airway Pressure (PAP) Therapy
NCT07806851Phase 3Not yet recruiting
- Start
- Oct 2026
- Primary completion
- Mar 2029
01
Overview
A Phase 3 trial of UBT251 in obstructive sleep apnea (OSA), obesity. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
UBT251
03
Conditions
obstructive sleep apnea (OSA)obesity
Beyond the preview
Go deeper on NCT07806851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07806851.